New York, NY, United States of America

Chad May


 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002-2011

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Gene Therapy: The Contributions of Chad May

Introduction

Chad May is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of gene therapy. With a total of 3 patents, his work focuses on innovative solutions for treating hemoglobinopathies, including β-thalassemia and sickle-cell disease. His research has the potential to transform the lives of patients suffering from these conditions.

Latest Patents

Chad May's latest patents include groundbreaking advancements in vector encoding human globin genes. One of his notable inventions involves recombinant lentiviral vectors that encode a functional β-globin gene and large portions of the β-globin locus control regions. These vectors include DNase I hypersensitive sites HS2, HS3, and HS4, which facilitate the expression of β-globin when introduced into a mammal, such as a human, in vivo. Additionally, the vector may contain a region encoding dihydrofolate reductase, enhancing its therapeutic potential. This innovative approach allows for the transformation of hematopoietic progenitor or stem cells ex vivo, which can then be restored to the patient, significantly improving treatment outcomes.

Career Highlights

Chad May has worked with esteemed institutions such as Memorial Sloan Kettering Cancer Center and the University of Minnesota. His experience in these prestigious organizations has contributed to his expertise in gene therapy and the development of novel treatment strategies for hemoglobinopathies.

Collaborations

Chad May has collaborated with notable professionals in the field, including Michel Sadelain and Stefano Rivella. These partnerships have fostered a collaborative environment that encourages innovation and the advancement of gene therapy research.

Conclusion

Chad May's contributions to gene therapy through his innovative patents and collaborations highlight the importance of research in addressing complex medical challenges. His work continues to pave the way for new treatment options for patients with hemoglobinopathies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…